Compare TK & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TK | SPRY |
|---|---|---|
| Founded | 1973 | 2015 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 937.1M | 761.6M |
| IPO Year | 1995 | 2020 |
| Metric | TK | SPRY |
|---|---|---|
| Price | $12.00 | $8.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $40.00 |
| AVG Volume (30 Days) | 544.1K | ★ 1.3M |
| Earning Date | 05-06-2026 | 03-09-2026 |
| Dividend Yield | ★ 16.88% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $84,278,000.00 |
| Revenue This Year | N/A | $90.76 |
| Revenue Next Year | N/A | $81.70 |
| P/E Ratio | $13.43 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.65 | $6.66 |
| 52 Week High | $13.76 | $18.63 |
| Indicator | TK | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 54.04 | 41.76 |
| Support Level | $9.11 | $6.66 |
| Resistance Level | $13.76 | $10.44 |
| Average True Range (ATR) | 0.43 | 0.59 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 62.56 | 36.68 |
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.